CORE CONDITIONS Flashcards
Asthma: Description
Inflammation of the bronchioles. Obstructive respiratory disease because inflamed bronchioles obstruct air flow.
Bronchial wall contracts, mucosal surfaces become inflamed and mucus production increases
Asthma: Epidemiology
5-8% prevalence. More common in children. Can, grow out of it, be lifelong or be adult-onset
Asthma: Aetiology and RFx
- Allergic asthma (ATOPIC) associated with eczema and hayfever
- Exercise induced
- Cold weather induced
- Drug induced (NSAIDs)
- Stress/emotion reduced
- RF: smoking, infection, Beta-blockers
Mast cells degranulate and release histamine and IgE. Basophils may also degranulate and levels rise.
Asthma: Presentations (signs and symptoms)
- Intermittent dyspnoea
- Wheeze on expiration
- Cough (often worse at night and evening)
- Sputum
- Tachypnoea
- Hyperinflated chest
- Hyper-resonant percussion
Asthma: Differentials
Pulmonary Oedema COPD Large airway obstruction SVC obstruction Pneumothorax PE Bronchiectasis
Asthma: Ix and Dx
- PEF, Sputum Culture,
- BLOODS: FBC, U&E and CRP, cultures for infection
- ABG (might show decreased PaCO2 and PaO2 - due to hyperventilation)
- Decreased FEV1 and FVC, Increased RV.
- *There should be a >15% improvement in PEF after B2 agonists. ASTHMA IS REVERSIBLE
Asthma: Treatments
- Short-acting beta2 agonist (salbutamol)
- Steroid Inhalers (beclamethasone)
- Long-acting beta2 agonists (salmeterol)
COPD: Description
Progressive, obstructive disorder. Combination of chronic bronchitis and emphysematous change.
COPD: Types
Two types of presentation depending on whether bronchitis or emphysema is main problem:
- PINK-PUFFER: usually younger, less advanced. Bronchitis main problem
- BLUE-BLOATER: have much less alveolar ventilation, very lowPaO2 and PaCO2. Cyanosed. At risk of cor pulmonale
COPD: Epidemiology
10-20% of over 40%
COPD: Aetiology/Risk Factors
Almost always caused by smoking
COPD: Presentation (signs and symptoms)
- Persistent SOB worse on exertion
- Cough with sputum
- Wheeze
- Tachypnoea
- Accessory muscle use
- Hyperinflation
- Cyanosis
- Cor Pulmonale
COPD: Ix and Dx
FBC CXR (hyperinflation, decreased vascular markings) ECG: RVH (cor pulmonale) ABG (reduced PaO2) FEV1 <80% expected, increased TLC and RV Spirometry with trial steroids
COPD: Treatments
Stop smoking, treat sx. IRREVERSIBLE Weight loss Mucolytics Inhalers (Beta2Ags and steroids) Long term steroids: prednisolone PO or beclametasone Inhaled
Bronchial Carcinoma: Description
Mostly squamous cell tumours, some are adenocarcinomas.
SMALL CELL or LARGE CELL. Small cell more common
Bronchial Carcinoma: Epidemiology
19% of all cancers
27% of all deaths
Bronchial Carcinoma: Aetiology/Risk factors
Most often smoking
Asbestos, Chromium, arsenic, iron oxides and radiation also RFs
Bronchial Carcinoma: Presentation (Signs and Symptoms)
- Cough + Haemoptysis
- Weight loss
- Dyspnoea
- Chest Pain
- Recurrent or slowly resolving pneumonias
- Clubbing
- Anaemia
- Lymphadenopathy (supra-clavicular and axillary)
- Pleural effusions on CXR
- METS
Bronchial Carcinoma: Complications
Can be P/C
- Horner’s Syndrome (apical tumours/Pancoast tumours compress sympathetic chain: ptosis, miosis, anhidrosis)
- Brain sx (mets)
- Bone pain (mets)
- Lambert-Eaton (AI attacking neuromuscular junction, proximal limb muscle weakness)
Bronchial Carcinoma: Differentials
- COPD +/- acute exacerbation
- Pneumonia
- TB
Bronchial Carcinoma: Ix and Dx
- CXR (consolidation and effusions and poss. visible tumour)
- Sputum sample
- CT to stage the tumour
- Aspiration for cytology
- Bronchoscopy
Bronchial Carcinoma: Treatment
Different depending on whether it is small cell or non-small cell. NSCLC less likely to be disseminated (spread throughout lungs) hence better for excision and chemo/radio
SCLC can be treated with chemo/radio but invariably relapse
- CYCLOPHOSPHAMIDE, VINCRISTINE
Bronchial Carcinoma: Prognosis
NSCLC: 505 2 year survival (without spread.
SCLC: median survival is 3 months to 1.5 years if treated